.jpg "Rachel Strength, MD photo")
Clinical Fellow in Infectious Diseases
Children's National Hospital
Disclosure(s): Dexcom: Stocks/Bonds (Public Company); Johnson and Johnson: Stocks/Bonds (Public Company); Merck: Stocks/Bonds (Public Company); Thermo Fisher: Stocks/Bonds (Public Company); Vertex Pharmaceuticals: Stocks/Bonds (Public Company)
Dr. Rachel Strength is a fourth-year Medicine-Pediatrics Infectious Diseases fellow at the National Institute of Allergy and Infectious Diseases and Children's National Hospital. Her research focuses on clinically-important antimicrobial resistance genes in the neonatal gut microbiome, under the guidance of Dr. Suchitra Hourigan. Dr. Strength earned her bachelor's degree in biomedical engineering from Washington University in St. Louis, then attended Louisiana State University Health Sciences Center in Shreveport, LA for medical school. She completed her residency in Internal Medicine and Pediatrics at the University of Tennessee Health Science Center. She is board-certified in Internal Medicine, Pediatrics, and Adult Infectious Diseases, with Pediatric Infectious Diseases board eligibility anticipated after June 2026. She is especially interested in early-life resistome changes and how they relate to both maternal and infant antibiotic resistance development over time.